Evaluation of methodologies for indirect comparison of eplontersen and vutrisiran for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy

Relationship Between White Matter Hyperintensities and Blood Biomarkers of Axonal Injury and White Matter Integrity